PhytoPur Bio: three strains, one registration and data closed to the patient

• Scale. 3 strains in the list, in 6 pharmaceutical positions.
• What you won’t buy elsewhere. 2 of them are supplied exclusively by this manufacturer, so a break in their supply means a lack of these strains, not another version of them.
• Portfolio profile. Caryophyllene leads, in 3 out of 3 strains.
• Pedigrees. All strains from this manufacturer have an established pedigree with a specified source.

Who is PhytoPur Bio and where does the raw material of this brand come from?

PhytoPur Bio is a limited liability company based in Warsaw, which appears on the pharmacy label as the responsible entity for three positions of dried cannabis, not as their grower. It describes itself as a pharmaceutical company and distributor. The cultivation location is not provided in any material available without logging in.

The registration data is provided by the company itself in a leaflet for doctors and pharmacists: PhytoPur Bio sp. z o.o., al. Jana Pawła II 27 in Warsaw, KRS number 0000968820. The same address is repeated by the product cards of online pharmacies, which enter this company in the manufacturer field, not any grower from outside Poland. The company states that it utilizes experience in cultivation, processing, and distribution, as well as partnerships with industry leaders across Europe. No partner is named in this statement.

This same leaflet describes the company as a leading supplier of medical marijuana in Poland. The pharmacy inventory on which this statement is based does not confirm this: the brand is responsible for three cultivars out of eighty-five and for three positions out of one hundred forty-one, which is exactly the same as Suprobion and more than ten times less than S-LAB. Therefore, the statement about being a leader is a commercial declaration, not a verifiable number.

Where the raw material itself comes from is mentioned by one source, and it is not the manufacturer. A store blog states that the supplier of raw material for this brand is the Danish company Schroll Medical. The Schroll company’s own service describes cultivation near Odense and production in Denmark and Portugal, mentions the EU-GMP certificate and export to five markets, but does not mention either Poland or the PhytoPur Bio brand. Therefore, the connection stands on one commercial description, not on a document from either party.

Which PhytoPur Bio strains are available in Polish pharmacies?

Three. Big Purple Dragon and Frosted Lemon Angel are exclusive to this brand in this list, while Gorilla Glue is supplied by three other manufacturers alongside it. All three positions feature the same leading terpene, caryophyllene, which is not obvious with three different pedigrees.

Each of them has its own entry with a profile and pedigree in this list: Big Purple Dragon, Frosted Lemon Angel and Gorilla Glue. A full list of positions available in pharmacies is maintained in the list of medical marijuana strains, which also includes equivalents of the same names from other manufacturers.

Gorilla Glue is a separate case here, as this trade name is held by four manufacturers in Polish pharmacies at the same time. However, the name does not carry a declaration: each of them registers its own position with its own content and its own batch documentation. Moreover, in the portfolio from the company’s leaflet from 2025, Gorilla Glue does not appear at all, although two Polish pharmacy listings assign such a position to this brand.

Besides the dried cannabis, the leaflet mentions two positions of standardized extract described by the name Cairo, with a pedigree of Amnesia Haze x White Widow. The extract is not dried cannabis and does not enter this list, which describes only flowers. It appears here only to clarify that the brand’s portfolio is broader than the three names in our inventory.

How does PhytoPur Bio’s raw material differ from other suppliers?

On paper, nothing that could be verified at the source. However, it is distinguished by the registration method: two flower strains share one number provided in the leaflet, and the pharmacy profile database assigns all three the same registration name, without a cultivar indication. The rest of the differences come down to packaging and the recommended route of administration.

The registration name is “Cannabis flos PhytoPur Bio” and does not include the strain name. In the pharmacy profile database, all three cards of this brand indicate the same registration identifier, and the manufacturer’s leaflet assigns the same number described as the MAH number to both Big Purple Dragon and Frosted Lemon Angel. Therefore, the strain name acts as a trade designation added to one registration, not as a separate registration position.

The result is that the registration name itself does not determine which cultivar will be in the package. This is only determined by the strain designation on the series label or the wholesaler’s note, and only there can it be seen which of the three names is involved.

Little more is known about the process than what is conveyed by the packaging. The dried cannabis comes in ten-gram packages, and the leaflet indicates inhalation using a certified medical vaporizer as the recommended route of administration. Information about sterilization by beta radiation is carried by the store description, not the company’s material, so it is not a data confirmed by the manufacturer.

However, nothing distinguishes it from what would allow comparing batches between suppliers. Besides the gateway for doctors, there is no publicly available certificate of analysis for any batch, no plantation is named, and the company does not provide the manufacturing license number in open materials.

What is known, and what is not known about the raw material of this manufacturer?

What is known fits on the label and one leaflet. It is not known who cultivates the raw material, in which country the plantation is located, or what results a specific batch analysis yielded, as the company does not publish certificates of analysis in a place accessible to the patient, and its own service is closed to him by a gateway for doctors.

On the documentation side, there is what is visible on the pharmacy label: registration name, form, ten-gram packaging, and Rpw category. Additionally, there is a leaflet for medical professionals, in which the company provides its own registration data, a number described as MAH, the declared content of both main compounds, and the recommended route of administration. This is the entire resource.

The company’s service is not a source that a patient will consult. The site presents itself as an educational platform for medical professionals and requires a medical practice number along with a statement that the entrant is a doctor before entry. Everything the company publishes about its batches stands behind this gateway, and from the outside, it is not possible to verify even whether certificates of analysis are present there at all.

On the marketing material side, the rest stands. The terpene table in the leaflet adds a list of properties to each name, citing a general review work on the entourage effect from 2011 as the source, which is a text about the plant in general, not an analysis of this batch. Next to it is a list of potential areas of application, including support for weight reduction, without reference to any study on this raw material.

We do not provide numerical values for the profile shares, and this is not an over-caution. For the three cards of this brand in the pharmacy profile database, the values from the shares column sum up to 78, 86, and 99, while the manufacturer’s leaflet for the strain for which the database gives 99 lists a set summing up to 101. Four cards, four different denominators. In the Big Purple Dragon card, the list of names and the table with numbers do not even agree with each other: there are four names, and seven rows with numbers.

How quickly does this supplier’s dried cannabis act after vaporization?

Just as quickly as any other dried cannabis administered this way. The company’s leaflet states that the onset of action occurs within one to two minutes and that the effect lasts from one and a half to four hours, but does not indicate the measurement from which these numbers come or the batch on which it was performed.

The route of administration determines the course more than the strain itself. After vaporization, the substance passes from the lungs to the blood almost immediately, so the first sensations appear after a few minutes, the intensity increases for another ten to thirty minutes, and the whole effect wears off within two to four hours. After ingestion, the raw material first passes through the intestine and liver, so the first sensations are waited for from half an hour to two, and the episode lasts six, sometimes eight hours. Hence the most common mistake with oral administration: anyone who thinks nothing is happening after thirty minutes and adjusts the dose will receive both doses at once. The above ranges describe the route of administration, not this strain; pharmacokinetic studies for a single cultivar have not been published.

The leaflet also provides the release temperatures of individual components during vaporization, ranging from 130 to 177 degrees Celsius. The leaflet does not state where these values come from or whether they were measured on this raw material, and the difference between the vaporizer setting and the temperature of the dried cannabis itself is discussed in a separate entry.

What adverse effects have been reported after using this manufacturer’s raw material?

None, because no one collects them separately. Public listings do not separate reports by the manufacturer of the dried cannabis, and the company’s leaflet for doctors does not contain any section on adverse symptoms at all, although it lists potential areas of application, including those for which it does not provide any study on this raw material.

Reports of adverse effects are collected for a medicinal product with a batch number, not for a strain name, so the following pertains to cannabis as a group of raw materials. The most commonly reported effects are dry mouth, red eyes, and increased heart rate. Less frequently described are dizziness upon rapid standing, daytime drowsiness, and temporary worsening of short-term memory, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public listings for cannabis in Poland do not separate them by individual products.

In available sources, there is not even what some suppliers have: a case description in the literature or an inspection announcement about halting a batch. The silence of sources here is not evidence of safety, but a result of the brand’s short presence in the market and the fact that the reporting system operates on the batch number.

Are PhytoPur Bio strains consistently available in pharmacies?

No. Availability changes with batches and has already changed: in the pharmacy profile database, two positions of this brand have a status of high availability, while the third, Frosted Lemon Angel, is listed as unavailable, although it was the one related to the announcement of the first batch from the summer of 2025 when the brand entered the Polish market.

The permit pertains to the registration position, but batches reach the pharmacy, and a batch runs out. Therefore, the state from any listing, including this one, ages faster than the strain description: the pedigree and terpene set remain the same, while availability can change within weeks. The current state is checked in the pharmacy or in the drug availability search engine, not in an article from a few months ago.

The brand entered Polish pharmacies late, as the announcement of the first batch falls at the turn of July and August 2025. The short presence explains some of the gaps described above, but does not explain the lack of a public certificate of analysis, as this depends on the company’s decision, not on the time on the market.

Dried cannabis from the pharmacy is often confused with cannabis sold over the counter, and these are two different things under one word. The latter is found in the dried cannabis category in the store and there is no pharmacy position or any product from this brand there.

Frequently asked questions

Who is the producer of PhytoPur Bio strains?

On the pharmacy label, the responsible entity is PhytoPur Bio sp. z o.o. from Warsaw, KRS number 0000968820. It is not a grower: the company describes itself as a pharmaceutical company engaged in the distribution of its own and others’ brands.

Where does PhytoPur Bio’s raw material come from?

This cannot be determined from the company’s materials. The only source indicating the supplier is a store blog that mentions the Danish company Schroll Medical. The Schroll company’s service does not mention either Poland or this brand, so the connection remains unconfirmed by either party.

How many PhytoPur Bio strains are in Polish pharmacies?

Three: Big Purple Dragon, Frosted Lemon Angel, and Gorilla Glue. The first two are exclusive to this brand in this list, while the third is supplied by three other manufacturers under the same trade name.

Does PhytoPur Bio publish certificates of analysis?

No, not in a place accessible to the patient. The company’s service only allows entry after providing a medical practice number, and outside this gateway, there is no certificate of analysis for any batch. Whether any documents stand behind the gateway cannot be checked from the outside.

Do Big Purple Dragon and Frosted Lemon Angel have separate registrations?

No. The manufacturer’s leaflet provides the same number described as the MAH number for both, and the pharmacy profile database assigns the same registration identifier to all three strains of this brand. The strain name here is a trade designation added to one registration.

Can PhytoPur Bio dried cannabis be purchased without a prescription?

No. The dried cannabis of this brand belongs to the Rpw category, meaning it is issued only on a prescription marked for narcotic substances. Without such a prescription, the pharmacy will not issue it, and outside the pharmacy, it is not available in any form.

Dried cannabis is a pharmaceutical raw material issued by a doctor’s prescription in the Rpw category. The material is informational in nature and does not replace consultation with the attending physician or pharmacist’s advice.

Editorial text: editorial team ubucha.pl.